Ananda Developments

Directors

Shareholders

Announcements

Publications

Broker Coverage

Company and Advisors

Corporate Governance

Home

Updates

Investment Opportunity

Ubuntu

Welcome to the Ananda Developments investor hub.

Whether you're a shareholder, investor, or simply interested in what we're doing at Ananda, we're delighted to have you here on our Hub.

Ananda is dedicated to developing CBD-based medicines to treat complex, chronic inflammatory pain conditions. With 28 million people in the UK alone dealing with chronic pain and the NHS spending over £5 billion annually on musculoskeletal pain, there is a pressing need for better, more effective treatments.

Using our patent-pending MRX1 CBD formulation we are conducting Phase 2 randomised controlled trials into:

We believe in the transformative potential of cannabinoids, supported by a growing body of clinical and real-world evidence. Our commitment is to deliver:

The highest quality cannabinoid medicines, manufactured in the UK to the strictest pharmaceutical standards.

Robust clinical trial evidence through partnerships with world-leading researchers.

Cannabinoid medicines available on the NHS.

Our Hub is the place for our shareholders, investors, stakeholders and everyone interested in the potential of CBD-based medicines  to read our latest updates and announcements, and watch our videos. Have a question or comment? Send it through. We look forward to answering your questions.

To become a shareholder of Ananda, click here to go to IG Brokers to create an account.